OMNI
Shanghai
About OMNI
OMNI is an innovative pharmaceutical company focusing on the development of drug delivery technology. OMNI provides inhalation dosage forms, including inhalation aerosol, inhalation powder aerosol, inhalation nebulized solution, and nasal spray, and a design platform for supporting respiratory devices for asthma and chronic obstructive pulmonary disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $5.1M
- Funding stage: Late Stage Venture
- Last round: Series D (Dec 2021)
- Website: omni-pharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device, Pharmaceutical
Canonical: https://fsome.com/organization/omni-201472 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.